Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Diagnosis of hypercoagulable states].
Páramo JA, López Y, Muñoz C, Rodríguez-Calvillo M, Panizo C. Páramo JA, et al. Among authors: lopez y. Sangre (Barc). 1997 Dec;42(6):493-502. Sangre (Barc). 1997. PMID: 9490914 Review. Spanish. No abstract available.
Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain.
Tejada Meza H, Lambea Gil Á, Saldaña AS, Martínez-Zabaleta M, Juez PR, Martínez EL, Apilánez MC, Isasi MH, Enguita JM, Alfonso ML, Arenillas JF, Olaizola JS, Fernández JJT, Sánchez J, Castellanos-Rodrigo M, Roel A, Menéndez IC, Freijo M, Rodriguez AL, Portilla EP, López YJ, Castro ER, Rivas SA, García JT, Rodríguez IB, Julián-Villaverde F, García MPM, Trejo-Gabriel-Galán JM, Iñiguez AE, Juste CT, Lázaro CP, Moreno JM, On Behalf Of The Nordictus Investigators. Tejada Meza H, et al. Int J Stroke. 2020 Oct;15(7):755-762. doi: 10.1177/1747493020938301. Epub 2020 Jun 26. Int J Stroke. 2020. PMID: 32525468 Free PMC article.
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Lancet. 2025 Jan 18;405(10474):216-232. doi: 10.1016/S0140-6736(24)02551-0. Epub 2025 Jan 8. Lancet. 2025. PMID: 39798579 Clinical Trial.
253 results